Otsuka Pharmaceutical Co., Ltd.’s $250 million acquisition of Neurovance, Inc.

Ambrogio Visconti

McDermott Will & Emery acted as legal adviser to Neurovance, Inc. in its acquisition by a major Japanese pharmaceutical company Otsuka Pharmaceutical Co., Ltd. (OPC). Under…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here